Literature DB >> 16120478

Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.

Zafiroula Georgoussi1, Leonidas Leontiadis, Georgia Mazarakou, Manolis Merkouris, Karren Hyde, Heidi Hamm.   

Abstract

To define receptor subdomains important for protein interaction and identify components of novel signal transduction complexes for the mu- and delta-opioid receptors (mu-OR, delta-OR), we generated glutathione S-transferase fusion proteins of the carboxyl-termini of the mu-opioid receptor (mu-CT), the delta- (delta-CT), and the third intracellular loop of the delta-opioid receptor (delta-i3L) to search for interactive proteins. Results from pull down experiments have demonstrated for the first time that Gbetagamma complexes, derived from the heterotrimeric Galphatbeta1gamma1, purified Gbeta1gamma1, or Gbeta endogenously present in cell lysates and rat striatal extracts, interact with all mu- and delta-opioid receptor subdomains. On the other hand, the C-terminal peptides of the delta- and the mu-ORs exhibit differential profiles for Galpha subunit binding. Indeed, while mu-CT was unable to bind any form of Galpha, both the delta-CT and the delta-i3L displayed interactive regions for heterotrimeric Galphatbeta1gamma1, inactive Galpha(GDP) and active Galpha(GTPgammaS). Regulators of G protein signaling (RGS) proteins are another class of proteins that can modulate G protein signaling events. We demonstrate for the first time that RGS4 directly interacts with the mu-CT, the delta-CT as well as delta-i3L in a dose dependent manner. Moreover, RGS4 modulates mu-OR signaling and can form stable heterotrimeric complexes with the activated Galpha. Collectively, our data demonstrate that the C-termini of the mu- and delta-ORs provide direct physical scaffolding in which G protein subunits and RGS4 protein can be bound.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120478     DOI: 10.1016/j.cellsig.2005.07.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  35 in total

Review 1.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

2.  Molecular organization of the complex between the muscarinic M3 receptor and the regulator of G protein signaling, Gbeta(5)-RGS7.

Authors:  Simone L Sandiford; Qiang Wang; Konstantin Levay; Peter Buchwald; Vladlen Z Slepak
Journal:  Biochemistry       Date:  2010-06-22       Impact factor: 3.162

3.  Evidence for association of GABA(B) receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins.

Authors:  Catherine E Fowler; Prafulla Aryal; Ka Fai Suen; Paul A Slesinger
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

4.  Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation.

Authors:  Zhihui Xie; Zhao Yang; Kirk M Druey
Journal:  J Mol Cell Biol       Date:  2010-10-25       Impact factor: 6.216

Review 5.  How regulators of G protein signaling achieve selective regulation.

Authors:  Guo-Xi Xie; Pamela Pierce Palmer
Journal:  J Mol Biol       Date:  2006-11-15       Impact factor: 5.469

6.  A generic approach for the purification of signaling complexes that specifically interact with the carboxyl-terminal domain of G protein-coupled receptors.

Authors:  Pascal Maurice; Avais M Daulat; Cédric Broussard; Julien Mozo; Guilhem Clary; Françoise Hotellier; Philippe Chafey; Jean-Luc Guillaume; Gilles Ferry; Jean A Boutin; Philippe Delagrange; Luc Camoin; Ralf Jockers
Journal:  Mol Cell Proteomics       Date:  2008-04-29       Impact factor: 5.911

7.  Direct bidirectional μ-opioid control of midbrain dopamine neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Wakako Fujita; Howard L Fields
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

8.  Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.

Authors:  Aura C Meirsman; Julie Le Merrer; Lucie P Pellissier; Jorge Diaz; Daniel Clesse; Brigitte L Kieffer; Jérôme A J Becker
Journal:  Biol Psychiatry       Date:  2015-06-06       Impact factor: 13.382

9.  Regulation of mu opioid receptor internalization by the scaffold protein RanBPM.

Authors:  Jeffery N Talbot; Donald A Skifter; Elisabetta Bianchi; Daniel T Monaghan; Myron L Toews; L Charles Murrin
Journal:  Neurosci Lett       Date:  2009-09-27       Impact factor: 3.046

Review 10.  Fine-tuning of GPCR activity by receptor-interacting proteins.

Authors:  Stefanie L Ritter; Randy A Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.